Edwards Lifesciences (EW) Other Non Operating Income (2015 - 2026)

Edwards Lifesciences' Other Non Operating Income history runs 12 years deep, the most recent figure standing at $71.5 million for Q1 2026.

• On a quarterly basis, Other Non Operating Income rose 2650.0% year-over-year to $71.5 million in Q1 2026; TTM through Mar 2026 was $76.1 million, a 15.65% increase from a year earlier, with the FY2025 full-year figure at $7.2 million, down 89.55% from the prior year.
• Other Non Operating Income climbed to $71.5 million in Q1 2026 per EW's latest filing, from $3.2 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $71.5 million in Q1 2026 and bottomed at -$3.3 million in Q1 2022.
• The 5-year median for Other Non Operating Income is $3.2 million (2025), against an average of $9.8 million.
• Across the five-year window, Other Non Operating Income slumped 242.86% in 2022 and jumped 2650.0% in 2026, its largest moves.
• Year by year, Other Non Operating Income stood at $5.8 million in 2022, then slumped by 37.93% to $3.6 million in 2023, then jumped by 825.0% to $33.3 million in 2024, then sank by 90.39% to $3.2 million in 2025, then surged by 2134.38% to $71.5 million in 2026.
• Per Business Quant, the three latest EW Other Non Operating Income figures stand at $71.5 million (Q1 2026), $3.2 million (Q4 2025), and $2.7 million (Q3 2025).